The Clorox Company (NYSE:CLX) Shares Bought by abrdn plc

abrdn plc raised its holdings in shares of The Clorox Company (NYSE:CLX - Free Report) by 3.1% during the third quarter, according to its most recent filing with the SEC. The firm owned 560,714 shares of the company's stock after purchasing an additional 16,811 shares during the period. abrdn plc owned 0.45% of Clorox worth $90,956,000 at the end of the most recent reporting period.

Other institutional investors have also added to or reduced their stakes in the company. SG Americas Securities LLC increased its position in Clorox by 1,525.7% during the 1st quarter. SG Americas Securities LLC now owns 65,612 shares of the company's stock valued at $10,046,000 after purchasing an additional 61,576 shares during the period. Mizuho Markets Americas LLC boosted its holdings in shares of Clorox by 93.7% in the 1st quarter. Mizuho Markets Americas LLC now owns 72,053 shares of the company's stock valued at $11,032,000 after buying an additional 34,864 shares in the last quarter. CANADA LIFE ASSURANCE Co boosted its holdings in shares of Clorox by 15.2% in the 1st quarter. CANADA LIFE ASSURANCE Co now owns 141,622 shares of the company's stock valued at $21,705,000 after buying an additional 18,687 shares in the last quarter. Advisors Asset Management Inc. boosted its holdings in shares of Clorox by 257.5% in the 1st quarter. Advisors Asset Management Inc. now owns 11,228 shares of the company's stock valued at $1,719,000 after buying an additional 8,087 shares in the last quarter. Finally, Raymond James & Associates boosted its holdings in shares of Clorox by 32.8% in the 2nd quarter. Raymond James & Associates now owns 267,632 shares of the company's stock valued at $36,524,000 after buying an additional 66,149 shares in the last quarter. Hedge funds and other institutional investors own 78.53% of the company's stock.

Analyst Ratings Changes

A number of analysts have recently weighed in on the stock. Jefferies Financial Group upgraded shares of Clorox from a "hold" rating to a "buy" rating and raised their price target for the company from $174.00 to $187.00 in a report on Tuesday, October 1st. TD Cowen started coverage on shares of Clorox in a research note on Tuesday, July 23rd. They issued a "sell" rating and a $122.00 target price for the company. BNP Paribas upgraded shares of Clorox to a "strong sell" rating in a research note on Friday, September 6th. DA Davidson reiterated a "neutral" rating and issued a $153.00 target price on shares of Clorox in a research note on Friday, September 6th. Finally, Deutsche Bank Aktiengesellschaft lifted their target price on shares of Clorox from $144.00 to $151.00 and gave the stock a "hold" rating in a research note on Friday, August 2nd. Six equities research analysts have rated the stock with a sell rating, nine have assigned a hold rating and one has given a buy rating to the company. Based on data from MarketBeat, Clorox presently has a consensus rating of "Hold" and an average target price of $150.14.

Clorox Stock Performance

Shares of NYSE:CLX traded up $0.44 during trading on Wednesday, hitting $157.27. 734,790 shares of the stock traded hands, compared to its average volume of 1,220,431. The company has a quick ratio of 0.63, a current ratio of 1.03 and a debt-to-equity ratio of 5.04. The company has a market cap of $19.53 billion, a price-to-earnings ratio of 81.25, a P/E/G ratio of 3.19 and a beta of 0.41. The company has a fifty day moving average price of $161.02 and a two-hundred day moving average price of $145.82. The Clorox Company has a 52-week low of $114.68 and a 52-week high of $169.09.

Clorox (NYSE:CLX - Get Free Report) last posted its earnings results on Thursday, August 1st. The company reported $1.82 earnings per share for the quarter, beating the consensus estimate of $1.54 by $0.28. The firm had revenue of $1.90 billion during the quarter, compared to analyst estimates of $1.97 billion. Clorox had a net margin of 3.95% and a return on equity of 281.12%. As a group, equities analysts predict that The Clorox Company will post 6.64 EPS for the current year.

Clorox Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Thursday, November 7th. Investors of record on Wednesday, October 23rd will be issued a $1.22 dividend. This represents a $4.88 annualized dividend and a yield of 3.10%. The ex-dividend date is Wednesday, October 23rd. Clorox's payout ratio is presently 252.85%.

Insider Buying and Selling

In related news, EVP Angela C. Hilt sold 1,733 shares of the business's stock in a transaction on Friday, September 6th. The shares were sold at an average price of $165.52, for a total value of $286,846.16. Following the completion of the sale, the executive vice president now owns 13,471 shares of the company's stock, valued at approximately $2,229,719.92. The trade was a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.51% of the stock is owned by insiders.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.